Myocarditis in young men ‘probably’ linked to Pfizer vax, Israel says
A government investigation suggests the rate of the adverse event is far higher than the background population rate
New evidence has emerged for a ‘probable’ causal link between myocarditis seen in younger patients and Pfizer’s COVID-19 vaccine, Israeli health authorities say.
Their findings, based on an investigation of 275 cases of myocarditis among more than five million recipients of the mRNA vaccine, suggest males aged 16-19 could be most at risk.
